New Marijuana/Cannabis Study Findings Recently Were Reported by a Researcher at Nuffield Health [Cannabis-based medicinal products (CBMPs) for the treatment of Long COVID symptoms: current and potential applications].

Předmět:	POST-acute COVID-19 syndrome SARS-CoV-2
Zdroj:	Medical Letter on the CDC & FDA; 9/22/2023, p824-824, 1p
Abstrakt:	For more information on this research see: Cannabis-based medicinal products (CBMPs) for the treatment of Long COVID symptoms: current and potential applications. Keywords: Clinical Research; Clinical Trials and Studies; Coronavirus; Health and Medicine; Marijuana/Cannabis; RNA Viruses; Risk and Prevention; Viral; Virology EN Clinical Research Clinical Trials and Studies Coronavirus Health and Medicine Marijuana/Cannabis RNA Viruses Risk and Prevention Viral Virology 824 824 1 09/19/23 20230922 NES 230922 2023 SEP 18 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Fresh data on marijuana/cannabis are presented in a new report. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu